1. Home
  2. Analysis
  3. Zantac-150
  4. Xopenex

Zantac 150 and Xopenex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zantac 150 (ranitidine hydrochloride) and Xopenex (levalbuterol hydrochloride). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Zantac 150 and Xopenex. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Zantac 150?

Zantac 150 has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 6,519 Zantac 150 users. Check the latest studies of Zantac 150.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 13,816 Xopenex users. Check the latest studies of Xopenex.

On Jul, 19, 2026

17 people who take Zantac 150 and Xopenex together, and have interactions are studied.

Zantac 150 and Xopenex drug interactions.

What are the common drug interactions of Zantac 150 and Xopenex, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Brain damage
  4. Conjunctivitis (pink eye)
  5. Otitis media (inflammation of the middle ear)
  6. Respiratory distress (difficulty in breathing)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Respiratory syncytial virus infection (viral disease of respiratory system)
  9. Upper respiratory tract infection
  10. Ear discomfort

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephropathy toxic (damage to kidney due to toxins)
  4. Pneumonia
  5. Rash
  6. Renal tubular necrosis (death of kidney tubules)
  7. Sudden death
  8. Unresponsive to stimuli
  9. Vomiting
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

What are the common drug interactions of Zantac 150 and Xopenex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Brain damage
  2. Conjunctivitis (pink eye)
  3. Otitis media (inflammation of the middle ear)
  4. Respiratory distress (difficulty in breathing)
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Respiratory syncytial virus infection (viral disease of respiratory system)
  7. Upper respiratory tract infection
  8. Arrhythmia (irregular heartbeat)
  9. Intestinal perforation (complete penetration of the wall of the intestine)
  10. Rash

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Nephropathy (damage to or disease of a kidney)
  5. Renal failure (kidney dysfunction)
  6. Renal injury (kidney injury)

40-49:

  1. Chronic kidney disease
  2. Drug ineffective
  3. Nephropathy toxic (damage to kidney due to toxins)
  4. Renal failure (kidney dysfunction)
  5. Renal tubular necrosis (death of kidney tubules)

50-59:

  1. Chronic kidney disease
  2. Gastric cancer (stomach cancer)
  3. Renal failure (kidney dysfunction)

60+:

  1. Chronic kidney disease
  2. Ear discomfort
  3. Diarrhoea
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Hepatic failure (liver failure)
  7. Immune system disorder
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Nausea (feeling of having an urge to vomit)
  10. Osteoporosis (bones weak and more likely to break)

What are the existing conditions these people have? *

  1. High Blood Pressure: 7 people, 41.18%
  2. Pain: 7 people, 41.18%
  3. Depression: 6 people, 35.29%
  4. Blood Pressure Abnormal: 5 people, 29.41%
  5. High Blood Cholesterol: 4 people, 23.53%
  6. Infection: 4 people, 23.53%
  7. Stress And Anxiety: 4 people, 23.53%
  8. Muscle Spasms (muscle contraction): 3 people, 17.65%
  9. Cough: 3 people, 17.65%
  10. Diabetes: 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take Zantac 150 and Xopenex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zantac 150 and Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zantac 150:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zantac 150 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xopenex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride and levalbuterol hydrochloride (the active ingredients of Zantac 150 and Xopenex, respectively), and Zantac 150 and Xopenex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.